NAS10029,813+0.55%S&P7,744+0.28%GOLD$4,037−0.37%BTC$79,765−1.85%VIX17.26+2.07%latest tape · as of 08:02 UTC
The Screen · Real Estate · REIT - Residential
Invitation Homes
INVH · a US exchange · USD · Market cap $16.0B · 1,725 employees
Invitation Homes is a leading owner and operator of single-family homes for lease, offering residents high quality homes in sought after neighborhoods across the United States.
FAIL · Does not pass the screen
27.54 USD
Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 6 days ago
Screened 2026-10-23 · the tape above runs as of 08:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price27.54 USD at the 23 Oct 2026 close
Our ratingAvoid, current read accumulation
Ethical screenDoes not pass
OptionsOpen interest leans heavily to calls (put/call 0.67)
Last reviewed23 Oct 2026 (6 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 27.54 against the desk's fair-value range, base estimate 21.86, over the last year.
Positioning political selling, disclosed 2026-09-11
Options put/call open interest 0.67, read 2026-10-28
Ethical does not pass the values gate
Price27.54 USD
Fair value21.86
Ethical score10.0/100
RatingAVOID
Our investment reviews on this name
2026-10-22Read Accumulation27.07+1.7% to today ✓Markdown gives way to Accumulation after a 10% slide in 7 weeks
2026-09-02Read Markdown30.11-8.5% to today ✓Markup gives way to Markdown with volume flow in agreement
2026-07-02Read Markup30.04-8.3% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Invitation Homes holds its Accumulation at $27.54. The statistical read favours the buyers, held for 164 days.
As held on the ledger · 2026-10-23
Phase
Accumulation
Quantitative state
The statistical read favours the buyers, held for 164 days
Price at the screen
$27.54
Valuation
24.83 trailing · 38.08 forward price to earnings
Values screen
FAIL· score 10.0
Beta
0.83
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
44.86%
Below 33%
Interest-bearing debt is 44.9% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.34%
Below 33%
Cash held in interest-bearing accounts and securities is 0.3% of assets, under the one-third limit.
Pass
Receivables
1.02%
Below 49%
Money owed to the company is 1.0% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Invitation Homes's business is in a permissible area, but its interest-bearing debt is about 45% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when INVH's ethical verdict changes
Today INVH does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads AVOID: it trades above our $21.86 fair value estimate, narrow competitive moat, 10.10% revenue growth.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. The price runs 20.6% above the base estimate.
Third-party analyst targets: 23 covering, consensus Buy. The average target sits +20% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Single family rentals priced far beyond value
Picture a landlord with 86,000 homes across America. Invitation Homes looks like steady rental income at first glance, yet we pass for clear reasons. The shares sit at 30 dollars against a fair value of 21, and that gap alone rules it out.
Revenue rises 9 percent and margins reach 21 percent, but a 45 times forward multiple and 6 percent return on equity show the market is paying for perfection. The narrow moat offers little protection when rates or vacancies move against the sector.
Debt already fails the ethical screen, and the premium valuation leaves scant margin if housing cools. Consensus targets sit higher, yet the numbers point to overstretch rather than opportunity. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
INVH trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-28Accumulation$27.07+0.0%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (23 analysts) rates it buy, with a mean price target of $31. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Accumulation$27.07+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (23 analysts) rates it buy, with a mean price target of $31. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Accumulation$27.07+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (23 analysts) rates it buy, with a mean price target of $31. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Accumulation$27.07+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (23 analysts) rates it buy, with a mean price target of $31. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Accumulation$27.07+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (23 analysts) rates it buy, with a mean price target of $31. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Accumulation$27.07+0.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (23 analysts) rates it buy, with a mean price target of $31. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (23 analysts) rates it buy, with a mean price target of $31. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Markdown$27.07+0.0%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (23 analysts) rates it buy, with a mean price target of $31. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markdown$27.07+2.0%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (23 analysts) rates it buy, with a mean price target of $31.
2026-10-02Markdown$26.54-11.9%Entry 6
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 11.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (23 analysts) rates it buy, with a mean price target of $31.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
